| pubmed-article:19820023 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19820023 | lifeskim:mentions | umls-concept:C0346402 | lld:lifeskim |
| pubmed-article:19820023 | lifeskim:mentions | umls-concept:C1514559 | lld:lifeskim |
| pubmed-article:19820023 | lifeskim:mentions | umls-concept:C0034809 | lld:lifeskim |
| pubmed-article:19820023 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19820023 | pubmed:dateCreated | 2009-11-5 | lld:pubmed |
| pubmed-article:19820023 | pubmed:abstractText | Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. The Weiss score is the most widely accepted method for distinguishing an ACC from an adrenocortical adenoma (ACA); however, in borderline cases, accurate diagnosis remains problematic. We recently discovered that the glucocorticoid receptor (GR) gene NR3C1 is significantly up-regulated in ACCs compared with ACAs in global gene expression studies. | lld:pubmed |
| pubmed-article:19820023 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19820023 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19820023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19820023 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19820023 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19820023 | pubmed:issn | 1945-7197 | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:SvajcerKK | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:BotlingJohanJ | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:RobinsonBruce... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:ClarksonAdele... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:GillAnthony... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:Clifton-Bligh... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:StalbergPeter... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:TaconLyndal... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:SoonPatsy SPS | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:ChouAngela... | lld:pubmed |
| pubmed-article:19820023 | pubmed:author | pubmed-author:SkogseidBritt... | lld:pubmed |
| pubmed-article:19820023 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19820023 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:19820023 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19820023 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19820023 | pubmed:pagination | 4591-9 | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:meshHeading | pubmed-meshheading:19820023... | lld:pubmed |
| pubmed-article:19820023 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19820023 | pubmed:articleTitle | The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. | lld:pubmed |
| pubmed-article:19820023 | pubmed:affiliation | Cancer Genetics Unit, Hormones and Cancer Group, Kolling Institute of Medical Research, University of Sydney, Sydney, NSW 2006, Australia. ltacon@med.usyd.edu.au | lld:pubmed |
| pubmed-article:19820023 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19820023 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
